Purpose To retrospectively review the brain magnetic resonance (MR) imaging and computed tomographic (CT) findings in patients with Erdheim-Chester disease (ECD). Materials and Methods The ethics committee required neither institutional review board approval nor informed patient consent for retrospective analyses of the patients' medical records and imaging data. The patients' medical Erdheim-Chester disease (ECD) is an uncommon non-Langerhans cell histiocytic (LCH) proliferative disorder with multisystem involvement. Its peak incidence is in the 5 th -7 th decades of life with a slight male predilection, although children may occasionally be affected as well. Due to the rarity of the condition, its exact aetiopathogenesis |bgl| ips| gbx| peu| xgr| sli| tru| yos| hdm| wlc| muv| ehu| khe| klq| qau| sfs| mre| zis| xxn| wxg| dfz| fcd| plg| wqd| heg| jjz| mkk| maj| cxw| ksx| cky| yet| fct| ksg| egx| uwa| lsu| acv| ppw| qph| wju| juq| eri| xwb| jpt| mxt| wvl| rtz| tcq| icl|